Abstract | BACKGROUND: METHODS: We developed a cellular model of rapid amyloid deposition using cultured human islets and observed a correlation between fibril accumulation and beta-cell death. A series of overlapping peptides derived from IAPP was generated. RESULTS: A potent inhibitor (ANFLVH) of human IAPP aggregation was identified. This inhibitory peptide prevented IAPP fibril formation in vitro and in human islet cultures leading to a striking increase in islet cell viability. CONCLUSIONS: These findings indicate an important contribution of IAPP aggregation to beta-cell death in situ and point to therapeutic applications for inhibitors of IAPP aggregation in enhancing beta-cell survival. GENERAL SIGNIFICANCE: Anti- amyloid compounds could potentially reduce the loss of beta-cell mass in type 2 diabetes and maintain healthy human islet cultures for beta-cell replacement therapies.
|
Authors | Kathryn J Potter, Louise A Scrocchi, Garth L Warnock, Ziliang Ao, Marika A Younker, Lawrence Rosenberg, Mark Lipsett, C Bruce Verchere, Paul E Fraser |
Journal | Biochimica et biophysica acta
(Biochim Biophys Acta)
Vol. 1790
Issue 6
Pg. 566-74
(Jun 2009)
ISSN: 0006-3002 [Print] Netherlands |
PMID | 19264107
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amyloid
- Islet Amyloid Polypeptide
|
Topics |
- Amino Acid Sequence
- Amyloid
(antagonists & inhibitors, metabolism)
- Animals
- Apoptosis
(physiology)
- Cell Survival
(physiology)
- Cells, Cultured
- Humans
- Islet Amyloid Polypeptide
- Islets of Langerhans
(physiology, ultrastructure)
- Molecular Sequence Data
|